List of Excipients in API nitrofurantoin monohydrate/macrocrystalline
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nitrofurantoin monohydrate/macrocrystalline
Detailed excipient profiles for nitrofurantoin monohydrate/macrocrystalline
Excipient focus: CARBOMER 934
nitrofurantoin monohydrate/macrocrystalline drug variants containing CARBOMER 934
nitrofurantoin monohydrate/macrocrystalline drug variants not containing CARBOMER 934
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
nitrofurantoin monohydrate/macrocrystalline drug variants containing CARBOMER HOMOPOLYMER TYPE B
nitrofurantoin monohydrate/macrocrystalline drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CROSPOVIDONE
nitrofurantoin monohydrate/macrocrystalline drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | nitrofurantoin monohydrate/macrocrystalline | 63187-263 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate/macrocrystalline drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
nitrofurantoin monohydrate/macrocrystalline drug variants containing D&C YELLOW NO. 10
nitrofurantoin monohydrate/macrocrystalline drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
nitrofurantoin monohydrate/macrocrystalline drug variants containing FD&C BLUE NO. 1
nitrofurantoin monohydrate/macrocrystalline drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
nitrofurantoin monohydrate/macrocrystalline drug variants containing FD&C RED NO. 40
nitrofurantoin monohydrate/macrocrystalline drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
nitrofurantoin monohydrate/macrocrystalline drug variants containing GELATIN
nitrofurantoin monohydrate/macrocrystalline drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
nitrofurantoin monohydrate/macrocrystalline drug variants containing LACTOSE
nitrofurantoin monohydrate/macrocrystalline drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nitrofurantoin monohydrate/macrocrystalline drug variants containing MAGNESIUM STEARATE
nitrofurantoin monohydrate/macrocrystalline drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
nitrofurantoin monohydrate/macrocrystalline drug variants containing POVIDONE
nitrofurantoin monohydrate/macrocrystalline drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | nitrofurantoin monohydrate/macrocrystalline | 33261-160 |
| Proficient Rx LP | nitrofurantoin monohydrate/macrocrystalline | 63187-263 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
nitrofurantoin monohydrate/macrocrystalline drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | nitrofurantoin monohydrate/macrocrystalline | 33261-160 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate/macrocrystalline drug variants not containing POVIDONES
Excipient focus: STARCH, CORN
nitrofurantoin monohydrate/macrocrystalline drug variants containing STARCH, CORN
nitrofurantoin monohydrate/macrocrystalline drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
nitrofurantoin monohydrate/macrocrystalline drug variants containing SUCROSE
nitrofurantoin monohydrate/macrocrystalline drug variants not containing SUCROSE
Excipient focus: TALC
nitrofurantoin monohydrate/macrocrystalline drug variants containing TALC
nitrofurantoin monohydrate/macrocrystalline drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nitrofurantoin monohydrate/macrocrystalline drug variants containing TITANIUM DIOXIDE
nitrofurantoin monohydrate/macrocrystalline drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
